LifeCodexx En Route to Launching Sequencing-Based Trisomy 21 Test by Year End
April 19, 2011
LifeCodexx En Route to Launching Sequencing-Based Trisomy 21 Test by Year End
LifeCodexx recently completed a pilot study of 45 patients on Illumina's Genome Analyzer, but plans to switch to the HiSeq 2000 for a clinical validation study and for the commercial version of the test.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Sequenom Outlicenses Technology for T21 Test, Returns Rights of Separate Patent to TrovaGene
August 17, 2011 / Clinical Sequencing News - LifeCodexx Begins Clinical Validation Study of Sequencing-Based T21 Test
June 29, 2011 / Clinical Sequencing News - Some Proteomics Firms Exploring Next-Generation Sequencing for Biomarker Research
May 6, 2011 / ProteoMonitor - Sequencing-Based Fetal Testing Market Heats up as Verinata Plans 2012 Launch for Down Syndrome Dx
May 4, 2011 / Clinical Sequencing News - Prenatal Sequencing Becoming Standard of Care in Increasingly Litigious Market
January 16, 2013 / Clinical Sequencing News